Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2013 1
2014 1
2016 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Azithromycin use in paediatrics: A practical overview.
Ovetchkine P, Rieder MJ; Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee. Ovetchkine P, et al. Paediatr Child Health. 2013 Jun;18(6):311-6. Paediatr Child Health. 2013. PMID: 24421702 Free PMC article.
It is associated with pneumococcal resistance and, with stated exceptions, is generally not recommended for the treatment of acute pharyngitis, acute otitis media or pneumococcal community-acquired pneumonia in the paediatric population....
It is associated with pneumococcal resistance and, with stated exceptions, is generally not recommended for the treatment of acute pharyngit …
Folate and neural tube defects: The role of supplements and food fortification.
Ami N, Bernstein M, Boucher F, Rieder M, Parker L; Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee. Ami N, et al. Paediatr Child Health. 2016 Apr;21(3):145-54. doi: 10.1093/pch/21.3.145. Paediatr Child Health. 2016. PMID: 27398055 Free PMC article.
Intermittent concerns have been raised concerning possible deleterious effects of folate supplementation, including the masking of symptoms of vitamin B12 deficiency and an association with cancer, especially colorectal cancer. Both concerns have been disproved. The Canadian
Intermittent concerns have been raised concerning possible deleterious effects of folate supplementation, including the masking of symptoms …
Is the medical use of cannabis a therapeutic option for children?
Rieder MJ; Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee. Rieder MJ, et al. Paediatr Child Health. 2016 Jan-Feb;21(1):31-4. doi: 10.1093/pch/21.1.31. Paediatr Child Health. 2016. PMID: 26941559 Free PMC article.
The potential for cannabis as a therapeutic agent must be evaluated carefully for both efficacy and safety in treating specific paediatric health conditions. Smoking is not an acceptable mode of drug delivery for children. The use of cannabis for medical purposes in specif …
The potential for cannabis as a therapeutic agent must be evaluated carefully for both efficacy and safety in treating specific paediatri
Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months of age.
Friedman JN, Rieder MJ, Walton JM; Canadian Paediatric Society, Acute Care Committee, Drug Therapy and Hazardous Substances Committee. Friedman JN, et al. Paediatr Child Health. 2014 Nov;19(9):485-98. doi: 10.1093/pch/19.9.485. Paediatr Child Health. 2014. PMID: 25414585 Free PMC article.
Treating cough and cold: Guidance for caregivers of children and youth.
Goldman RD; Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee. Goldman RD, et al. Paediatr Child Health. 2011 Nov;16(9):564-9. doi: 10.1093/pch/16.9.564. Paediatr Child Health. 2011. PMID: 23115499 Free PMC article.
A meta-analysis summarizing trials using OTC CCMs for viral-induced cough found no evidence for or against the use of OTC medicines in both paediatric and adult populations when cough frequency and severity, as well as physician assessments, were compared. ...
A meta-analysis summarizing trials using OTC CCMs for viral-induced cough found no evidence for or against the use of OTC medicines in both …
Drug research and treatment for children in Canada: A challenge.
Rieder MJ; Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee. Rieder MJ, et al. Paediatr Child Health. 2011 Nov;16(9):560-1. doi: 10.1093/pch/16.9.560. Paediatr Child Health. 2011. PMID: 23115497 Free PMC article.
Many drugs have not been studied or labelled for use in children and adolescents, making the development and definition of optimally safe and effective drug therapies for the paediatric age group an ongoing challenge. Over the past decade, networks have developed in the Un …
Many drugs have not been studied or labelled for use in children and adolescents, making the development and definition of optimally safe an …
Feedback